Visx claims US first for CustomVue eye laser:
This article was originally published in Clinica
Executive Summary
Visx has received FDA approval for what it claims to be the first US-approved wavefront-guided laser treatment for hyperopia. The CustomVue laser vision correction procedure, which was also approved for treating astigmatism, uses the firm's WaveScan technology, a diagnostic system that captures a comprehensive "fingerprint" of each eye and generates an individualised treatment for each CustomVue procedure. "We believe this further advancement of laser vision correction technology will enhance our market leadership position, drive CustomVue conversions, and increase future revenue and profit opportunities," said Liz Davila, the Santa Clara, California firm's chairman and CEO.